Skip to Main Content

Paper Details

Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''.
Br J Cancer
1
2017
anti-CTLA-4 antibody, metastatic melanoma, patients
Author NameAffiliation
Grant A McArthurPeter MacCallum Cancer Centre
Grant A McArthurPeter MacCallum Cancer Centre
Jonathan CebonOlivia Newton-John Cancer Centre, Austin Hospital
Jonathan CebonOlivia Newton-John Cancer Research Institute
Georgina V LongMelanoma Institute Australia
Georgina V LongUniversity of Sydney
  • 1 - 6

Datasets

Release 1.2